Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $260.0 to $450.0 for UnitedHealth Group over the last 3 months.

Optum Ventures backs oncology AI startup Risa Labs in an $11.1M series A to accelerate AI platform deployment in U.S. cancer care settings.

Delaware Attorney General Kathy Jennings is suing several drug manufacturers and pharmacy benefit managers for reported ...

Insurance giant UnitedHealthcare is rolling out a new program that aims to support the finances of cash-strapped rural ...

DELRAY BEACH, Fla., Jan. 14, 2026 /PRNewswire/ -- Caron Treatment Centers, an internationally recognized nonprofit dedicated to transforming lives through addiction and behavioral healthcare treatment ...

Small told the Port Angeles Business Association on Tuesday at Joshua’s Restaurant that core challenges facing the emergency ...

UnitedHealth's earnings also suffered last year, as the company underestimated the rising cost of care and patients' ...

AI startup RISA Labs raises $11.1M Series A to scale its AI operating system for oncology, cutting authorization delays, ...

A public risk pool in Illinois is taking on some of the biggest names in pharma and health insurance over insulin pricing.

The controversial healthcare conglomerate is accused of systematically diagnosing patients with as many conditions as ...

Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO ...